Topic: mobile health apps
Sharecare, the personal healthcare platform, is ramping up—and taking brand partners in pharma with it.
Health-tracking consumers tend to self-medicate, says Kantar Health, finding at-risk populations using mHealth turn more often to OTC drugs.
The first product from Novo Nordisk’s partnership with diabetes health tech startup Glooko has arrived.
The drive to digital health runs straight through pharma territory, so it’s not surprising that many traditional drug companies are working on solutions.
Johnson & Johnson, pushing empathy as a tool to connect with consumers, is using product-paired apps as a way to do well by doing good.
Pharma app development needs to move beyond traditional practices that haven't included the patient perspective, says one industry consultant.
Wireless sensors that clip to cows’ ears are helping farmers monitor activity levels and feeding patterns of the animals, and by extension improving the monitoring for early signs of disease. Now, several companies are angling to grab a piece of this growing market.
Pfizer is going beyond the pill with its latest mental health offering.
Pharma companies are discovering that developing apps and digital health technologies is just like developing drugs--at least when it comes to persuading payers to cover them.
Could healthcare apps work better if they were supported by population management systems?